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Summary
 
Within T cell–rich areas of secondary lymphoid organs, interdigitating dendritic cells recruit
antigen-specific T cells that then induce B cells to secrete Igs. This study investigates the possi-
ble role(s) of dendritic cells in the regulation of human B cell responses. In the absence of ex-
ogenous cytokines, in vitro generated dendritic cells (referred to as Dendritic Langerhans cells,
D-Lc) induced surface IgA expression on 
 
z
 
10% of CD40-activated naive sIgD
 
1
 
 B cells. In the
presence of IL-10 and TGF-
 
b
 
, a combination of cytokines previously identified for its capacity
to induce IgA switch, D-Lc strongly potentiated the induction of sIgA on CD40-activated na-
ive B cells from 5% to 40–50%. D-Lc alone did not induce the secretion of IgA by CD40-acti-
vated naive B cells, which required further addition of IL-10. Furthermore, D-Lc skewed to-
wards the IgA isotype at the expense of IgG, the Ig production of CD40-activated naive B cells
cultured in the presence of IL-10 and TGF-
 
b
 
. Importantly, under these culture conditions,
both IgA
 
1
 
 and IgA
 
2
 
 were detected. In the presence of IL-10, secretion of IgA2 by CD40-acti-
vated naive B cells could be detected only in response to D-Lc and was further enhanced by
TGF-
 
b
 
. Collectively, these results suggest that in addition to activating T cells in the extrafolli-
cular areas of secondary lymphoid organs, human D-Lc also directly modulate T cell–depen-
dent B cell growth and differentiation, by inducing the IgA isotype switch.
 
D
 
endritic cells (DC)
 
1
 
 transport antigen from their port
of entry to the T cell–rich areas of secondary lym-
phoid organs (for review see reference 1). In these organs,
DC present processed antigen to specific T cells that prolif-
erate and differentiate into effector T cells as a consequence
of signals transmitted through molecules such as CD40,
CD40L, CD80-CD86, and CTLA4-CD28. It is currently
believed that these activated-helper T cells turn on specific
B cell responses. Whereas dendritic cells clearly contribute
to the development of humoral responses (2–4), the extent
to which they directly affect B cell growth and differentia-
tion remains to be determined. Studies of the role of hu-
man dendritic cells in the regulation of the immune re-
sponse have been hampered by the problem of getting
purified cells in sufficient quantities. With the establishment
of techniques allowing their generation in vitro either from
hematopoietic progenitors (5, 6) or from monocytes (7, 8),
this difficulty is now alleviated. Dendritic Langerhans cells
(D-Lc) can be generated in vitro by culturing human
CD34
 
1
 
 hematopoietic progenitors in the presence of GM-
CSF and TNF
 
a 
 
(5). These cells express a functional CD40
antigen that induces D-Lc to secrete cytokines (9) and to
mature into cells sharing characteristics of interdigitating
DC such as the expression of high levels of accessory mole-
cules (9).
Numerous studies have dealt with the molecular mecha-
nisms regulating B and T cell interactions (10, 11). Among
those, the receptor/ligand pair, CD40/CD40L, plays a ma-
jor role (12–14). In humans, CD40 triggering is critical for
the induction of isotype switching as best exemplified in
the Hyper-IgM syndrome (15, 16) where a genetic alter-
ation of the CD40L results in a deficit of circulating IgG
and IgA and the absence of germinal centers. To determine
the capacity of a given cytokine to induce isotype switch-
ing, we have developed a system in which human tonsillar
naive B cells, isolated on the basis of sIgD expression (17),
are cultured on surrogate-activated T cells composed of
CD40L-transfected fibroblasts (12). In this model, IL-4 or
IL-13 induces specific isotype switching towards IgE and
IgG
 
4 
 
(18–20), while IL-10 induces the switch towards IgG1
and IgG3 (21, 22). IL-10 may also induce the switch to-
wards IgA as CD40-activated naive sIgD
 
1
 
 B cells were
shown to produce IgA, albeit in quantities lower than that
of IgG (17). The production of IgA becomes prominent in
response to a combination of IL-10 and TGF-
 
b
 
 (17).
 
1
 
Abbreviations used in this paper:
 
 CD40L, CD40 ligand; CD40L-L cells,
CD40L-transfected L cells; DC, dendritic cells; D-Lc, dendritic Langerhans
cells; sIg, surface immunoglobulins; IL-10, interleukin 10; TGF-
 
b
 
, trans-
forming growth factor 
 
b
 
.
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To determine the possible existence of direct interactions
between D-Lc and B cells in a T cell–dependent context,
we used in vitro generated D-Lc obtained by culturing
CD34
 
1
 
 cells with GM-CSF and TNF
 
a
 
. In this study, we
demonstrate that D-Lc skew isotype switching of CD40-
activated naive B cells towards IgA.
 
Materials and Methods
 
Reagents.
 
The CD40-L–transfected Ltk
 
2
 
 cell line (CD40L-L
cells) was generated in our laboratory (23). rhGM-CSF (specific
activity: 2 
 
3
 
 10
 
6 
 
U/mg; Schering-Plough Research Institute, Ke-
nilworth, NJ) was used at a saturating concentration of 200 ng/ml.
rhTNF
 
a
 
 (specific activity: 2 
 
3
 
 10
 
7
 
 U/mg; Genzyme, Boston, MA)
was used at an optimal concentration of 2.5 ng/ml (24). rhSCF
(specific activity 2
 
 3 
 
10
 
5
 
; R&D, Abingdon, UK) was used at op-
timal concentration of 25 ng/ml. rhIL-10 (10
 
7
 
 U/mg; Schering-
Plough Research Institute) was used at 200 ng/ml. rhIL-2 (3
 
 3
 
10
 
6
 
 U/mg; Amgen, Thousand Oaks, CA) was used at 20 U/ml.
TGF-
 
b
 
1 
 
(R&D)
 
 
 
was used at 0.3 ng/ml (unless otherwise stated)
and polyclonal anti–TGF-
 
b 
 
antibody (R&D) was used at 50 
 
m
 
g/ml.
Monoclonal anti–IL-10 receptor antibody (mAb 3F9) was gener-
ated by Dr. K. Moore (DNAX Research Institute, Palo Alto, CA)
and used at 10 
 
m
 
g/ml. The neutralizing property of mAb3F9 was
tested for its capacity to inhibit CD40-activated B cell prolifera-
tion and differentiation induced by IL-10 (25).
 
Isolation of sIgD
 
1
 
 B Lymphocytes.
 
B cells were isolated from
tonsils as described earlier by the Ficoll-Rosetting method (17).
Purified sIgD
 
1
 
 
 
B lymphocytes were separated using a preparative
magnetic cell sorter (MACS; Miltenyi Biotec GmbH, Bergisch
Gladbach, Germany) according to the experimental procedure de-
scribed in detail by Miltenyi et al. (26). IgD was expressed on
 
.
 
99% of the sIgD
 
1
 
 
 
B cell subpopulation as assessed by fluores-
cence analysis using a FACScan
 
Ò
 
 (Becton Dickinson & Co.,
Mountain View, CA).
 
Purification of Cord–Blood CD34
 
1
 
 
 
Cells.
 
Umbilical cord blood
samples were obtained according to institutional guidelines. Cells
bearing CD34 antigen were isolated from mononuclear fractions
through positive selection with an anti-CD34 monoclonal anti-
body (Immu-133.3; Immunotech, Marseille, France) using a pre-
parative magnetic cell sorter (MiniMACS; Miltenyi).
 
Generation of D-Lc from CD34
 
1
 
 Cells.
 
Cultures were established
in the presence of GM-CSF, TNF
 
a
 
, and rhSCF in medium con-
sisting of RPMI 1640 (GIBCO BRL, Gaithersburg, MD) supple-
mented with 10% (vol/vol) heat-inactivated FCS (Flow Laboratories,
Irvine, UK), 10 mM Hepes (GIBCO BRL), 2 mM 
 
l
 
-glutamine
(Eurobio, Les Ullis, France) and gentamicin (0.08 
 
m
 
g/ml) (Scher-
ing-Plough, Levallois Perret, France). CD34
 
1
 
 
 
cells were seeded for
expansion in 25–150-cm
 
2
 
 flasks (Corning Glass, Corning, NY) at
2
 
 3 
 
10
 
4
 
 cells/ml. Optimal conditions were maintained by splitting
these cultures at day 5 and 10 with medium containing fresh
GM-CSF and TNF-
 
a
 
. Cells were routinely collected after 12 d of
culture when the cultures contained between 50–90% of CD1a
 
1
 
dendritic cells (FITC-labeled anti-CD1a mAb; OKT6, Ortho Di-
agnostic System, Raritan, NJ) (5).
 
Culture in the CD40L System.
 
All cultures were performed in
Iscove’s medium enriched with 50 
 
m
 
g/ml human transferrin, 5
 
m
 
g/ml bovine insulin, 0.05% BSA (all from Sigma Chemical Co.,
St. Louis, MO), 5% FCS (Flow Laboratories), 2 mM 
 
l
 
-glutamine
(Eurobio) and gentamicin (0.08 
 
m
 
g/ml) (Schering-Plough). Un-
less otherwise stated, for B cell proliferation and Ig secretion, 5
 
 3
 
10
 
4
 
/ml sIgD
 
1
 
 B cells and 5
 
 3 
 
10
 
4
 
/ml D-Lc (irradiated at 3,400
rad or non irradiated) were cultured in the presence of 1.25
 
 3
 
10
 
4
 
/ml irradiated (7,500 rad) CD40L-transfected L cells (CD40L-L
cells) cells in a final volume of 200 
 
m
 
l. For B cell proliferation, cells
were pulsed 24 h with [
 
3
 
H]TdR at day 6. [
 
3
 
H]TdR uptake was
measured by standard liquid scintillation counting techniques af-
ter harvesting. For phenotypic studies, the same concentration of
cells was used for 7 d in a final volume of 1 ml.
 
RNA Isolation and PCR Amplification.
 
Total RNA was ex-
tracted from 0.5 to 1
 
 3 
 
10
 
6
 
 of each cell type studied: Epstein-Barr
virus (EBV) cell line (JY), T cell clone (MT9), in vitro generated
dendritic cells, sIgD
 
1
 
 B cells alone and cocultured with dendritic
cells. RNA was isolated by the guanidine thiocyanate method
(27). Total RNA was reverse transcribed into cDNA using a ran-
dom hexamer primer (Pharmacia, Upsala, Sweden) and Super-
Script RNase H
 
2
 
 reverse transcriptase (GIBCO BRL) in a 20 
 
m
 
l
final volume. The PCR was performed as described in standard
protocols with 0.5 
 
m
 
l of the cDNA preparation, 0.1 mM of each
dNTP, 0.1 
 
m
 
g of each primer and 2.5 U TaqI DNA polymerase
(Perkin Elmer, Norwalk, CT) in 100 
 
m
 
l PCR buffer (Perkin El-
mer). The temperature profile used in 35 cycles of amplification
was 1 min at 94
 
8
 
C, 1 min at 60
 
8
 
C and 2 min at 74
 
8
 
C per cycle.
Oligonucleotide primers used for the PCR amplification were: sense
CD3 5
 
9
 
-AAGATGGTTCGGTACTTCTGACTTGTG-3
 
9
 
, an-
tisense CD3 5
 
9
 
-GTAGAGCTGGTCATTGGGCAACAGAGT-3
 
9
 
,
and sense 
 
b
 
-actin 5
 
9
 
-CTAGAAGCATTTGCGGTGGACGAT-
GGAGGG-3
 
9
 
, antisense 
 
b
 
-actin 5
 
9
 
-TGACGGGGTCACCCA-
CACTGTGCCCATCTA-3
 
9
 
. The size of the PCR products were
567 and 661 bp for CD3 and 
 
b
 
-actin, respectively.
 
Immunoglobulin Quantification.
 
For immunoglobulin quantifi-
cation, supernatants were harvested after 14 d of culture and IgG,
IgA and IgM levels were determined by ELISA as described else-
where (28). For titration of human IgA1, flat-bottomed microti-
ter plates are first coated with a rabbit anti–human IgA (dilution
1:10
 
4
 
; Behring, Rueil-Malmaison, France), in carbonate buffer
(pH 9.6). After incubation for 4 h at 37
 
8
 
C, the plates are then
washed and saturated in PBS (0.05% Tween, 5% FCS) and incu-
bated overnight at 4
 
8
 
C. Dilutions of culture supernatants in PBS
(0.05% Tween, 5% FCS) are then added to plates and incubated
for 2 h at room temperature. After washing, plates are incubated
with mouse anti–human IgA1 (dilution of ascite at 1:10
 
3
 
; Nor-
dimmune, The Netherlands) for 2 h at room temperature. Plates
are then washed and a goat anti–mouse IgG (Dako, Glostrup
Denmark) coupled to phosphatase alcaline is added at a final dilu-
tion of 1:2,000 in PBS (0.05% Tween, 2% FCS) during 2 h at
room temperature. After washing, 
 
p
 
-nitrophenyl phosphate in 1 M
diethanolamine-HCl buffer, pH 9.8, is added to plates, then al-
lowed to react at 37
 
8
 
C for 30–90 min before measurement of the
optical density at 405 and 490 nm with an automated device
(VMAX ELISA reader; Molecular Devices, Palo Alto, CA).
For titration of human IgA2, flat-bottomed microtiter plates
are first coated with a rat anti–mouse IgG1 (mAb LO-MG1-13;
University of Louvain, Brussels, Belgium) at 5 
 
m
 
g/ml in carbon-
ate buffer (pH 9.6). After incubation for 4 h at 37
 
8
 
C, the plates
are washed in PBS (0.05% Tween) and incubated with mouse
anti–human IgA2 (dilution of ascite at 1:10
 
3
 
; Nordimmune) over-
night at 4
 
8
 
C. Plates are washed and dilutions of culture superna-
tants in PBS (0.05% Tween, 4% nonfat milk) are added to plates
and incubated for 2 h at room temperature. After washing, plates
are incubated with a rabbit anti–human IgA coupled to phos-
phatase alcaline added at a final dilution of 1:1,000 in PBS (0.05%
Tween, 4% nonfat milk) during 2 h at room temperature. After
washing, substrate to phosphatase alcaline is added and optical
density is measured as described above. For IgA1 and IgA2 quan- 
1911
 
Fayette et al.
titations, standards composed of 50% IgA1 kappa myeloma
(BP086; The Binding Site, LTD, Birmingham, UK) and 50% IgA1
lambda myeloma (BP087) or of 50% IgA2 kappa myeloma (BP088)
and 50% IgA2 lambda myeloma (BP089) are used as references.
The limits of sensitivity are 4 and 8 ng/ml for IgA1 and IgA2, re-
spectively.
 
FACS
 
Ò
 
 Analysis.
 
For cytofluorometry, FITC-labeled rabbit
polyclonal anti-IgA antibody was obtained from Dakopatts, FITC-
labeled goat polyclonal anti-IgG antibody was obtained from
Kallestad (Austin, TX). Viable cells were gated by non-incorpo-
ration of propidium-iodide. For IgA subclasses staining, FITC-
conjugated anti-human IgA1 or anti-human IgA2 (Nordimmune)
were used. The specificity of the signal was demonstrated using a
cloned EBV transformed cell line expressing only IgA1 generated
in our laboratory (VLMB325). For IgA2, a cloned EBV cell line
(HEL) expressing only IgA2 was established from a donor being
homozygous for a deletion encompassing A1-GP-G2-G4-E re-
ported elsewhere (29). Competition experiments were done us-
ing 50 
 
m
 
g/ml of human IgA1
 
k
 
 myeloma (BP086) 
 
1
 
 IgA1
 
l
 
 my-
eloma (BP087) or 50 
 
m
 
g/ml of human IgA2
 
k
 
 myeloma (BP088) 1
IgA2l myeloma (BP089) and then staining of each cell lines with
FITC-conjugated anti-IgA1 or anti-IgA anti-IgA2 antibodies were
performed. Labeling of the sIgA11 EBV clone (VLMB325) was
totally inhibited by IgA1l 1 k myelomas but not IgA2k 1 l
myelomas, while the labeling of the sIgA21 EBV clone (HEL)
was specifically inhibited by the IgA2k 1 l myelomas but not
IgA1k 1 l myelomas (Fig. 1).
Results
Dendritic Cells Increase the Proliferation of CD40-activated
Naive sIgD1 B Cells. We first studied whether the prolif-
eration of CD40-activated naive sIgD1 B cells was affected
by the addition of D-Lc (dendritic cells generated by cul-
turing CD341 progenitors in the presence of GM-CSF and
TNF-a for 12 d). As shown in Fig. 2 A, addition of 103 D-Lc
increased DNA synthesis of 104 CD40-activated naive B
cells. Maximum DNA synthesis was observed with 104 D-Lc,
the highest density of D-Lc tested (concentrations above 104
D-Lc resulted in medium impoverishment). The stimula-
tory effect of 104 D-Lc appeared at early time points (day
4), increased until day 6 and then diminished (Fig. 2 B). Sim-
ilar results were obtained when D-Lc were either irradiated
or not (Fig. 2, A and B). Naive B cells did not proliferate in
response to D-Lc when CD40L-L cells were omitted (data
not shown).
CD40-activated naive B cells showed enhanced prolifer-
ation in response to IL-10. Addition of D-Lc slightly en-
hanced IL-10–induced B cell proliferation (Fig. 2 C). TGF-b
neither enhanced nor inhibited the proliferation of CD40-
activated naive B cells in the presence or absence of IL-10
with or without D-Lc (Fig. 2 C). The enhanced DNA syn-
thesis observed in response to the addition of D-Lc, re-
sulted in increased numbers of viable B cells as measured
after 6 d (Fig. 2 D). Note that the numbers of viable B cells
recovered from cultures performed with TGF-b (0.1–3
ng/ml) were not markedly decreased (Fig. 2 D).
Dendritic Cells Induce CD40-activated Naive sIgD1 B Cells
to Express Surface IgA1 and IgA2. After 7 d of CD40 acti-
vation, the frequency of cultured naive B cells expressing
sIgA was always lower than 1–2% (Fig. 3 A). Upon addi-
tion of either DC alone or a combination of TGF-b and
IL-10, 6.5–10% of naive B cells expressed sIgA. Neither
IL-10 nor TGF-b alone were able to induce naive B cells
to express sIgA. However IL-10, and to a lower extent
TGF-b, can enhance sIgA expression induced by D-Lc.
D-Lc potentiated strikingly the induction of sIgA on CD40-
activated naive B cells induced by a combination of IL-10
Figure 1. Surface IgA1 and IgA2 labelings are specific. Cells (5 3 105) from a sIgA11 EBV clone (VLMB 325) and from a sIgA21 EBV clone (HEL)
were stained, respectively, with FITC-labeled anti-sIgA1 and -sIgA2 mAbs (dotted lines). Competition experiments were done by preincubating FITC-labeled
anti-sIgA1 or anti-sIgA2 (right) together with 50 mg/ml human IgA1l 1 k myelomas (left) or with 50 mg/ml human IgA1l 1 k myelomas, which were
then used to stain each EBV clone (black lines). Controls with unrelated mAb of the same isotype were overlapped in each panel (gray histograms).1912 Dendritic Cells Skew Isotype Switching Towards IgA1 and IgA2
and TGF-b from 6.5 up to 41.7% (mean 35 6 15%, n 5
6). 0.3 ng/ml of TGF-b induced an optimal increase of the
frequency of sIgA B cells generated in response to D-Lc
and IL-10 (Fig. 3 B). With regard to sIgG, IL-10 alone ap-
peared to be a strong inducer (from 3.3 to 11.6%), whereas
D-Lc alone displayed virtually no effect. Yet, D-Lc en-
hanced IL-10 induced expression of sIgG (from 11.6 to
16.9%) (Fig. 3 A). Importantly, D-Lc with TGF-b, inhib-
ited IL-10–induced sIgG expression at concentrations that
stimulated sIgA expression (Fig. 3 B). Further analysis of
the sIgA subclasses shows that 18.8% of CD40-activated
naive B cells expressed sIgA1, whereas 7.9% expressed sIgA2
after culture in the presence of IL-10, TGF-b, and D-Lc
(Fig. 3 C).
Induction of sIgA by Dendritic Cells Is Partially Dependent on
Endogenous TGF-b. As TGF-b and IL-10 can be readily
produced by CD40-activated B cells (30, 31), we ques-
tioned whether D-Lc–induced sIgA could be dependent
on the endogenous production of these cytokines. As
shown in Fig. 4, D-Lc–induced sIgA on B cells was not af-
fected by the addition of a neutralizing anti–IL-10 receptor
antibody. In contrast, addition of a neutralizing anti–TGF-b
polyclonal antibody significantly inhibited D-Lc–induced
sIgA on B cells. The combination of anti–IL-10 receptor
and anti–TGF-b antibodies had no further inhibitory effect
than that observed with the anti–TGF-b antibody alone.
The neutralizing properties of the antibodies were demon-
strated by the fact that (a) addition of anti–IL-10R mAb
blocked IL-10–induced sIgA expression in the presence of
D-Lc and (b) addition of anti–TGF-b blocked the potenti-
ating effect of TGF-b in response to D-Lc and IL-10. Fi-
nally, a toxic effect of anti–TGF-b antibody was excluded,
as high dose of TGF-b added exogenously reversed the in-
hibitory effect of the anti–TGF-b antibody (data not
shown). Thus endogenous TGF-b, but not IL-10, partially
contribute to the capacity of D-Lc to induce surface IgA
expression on CD40-activated naive B cells in the absence
of exogenous cytokines. However, our results indicate that
Figure 2. In vitro generated D-Lc enhance CD40-activated naive B cell proliferation. 5 3 104/ml highly purified sIgD1 B lymphocytes were cultured
in a final volume of 200 ml over 1.25 3 104/ml irradiated CD40L-L cells in the absence or with increasing numbers of D-Lc (irradiated or not) without
exogenous cytokine. Thymidine uptake, determined after 6 d (A), or at different indicated time points (B), is expressed as mean 6 SD of triplicate cul-
tures. (C) DNA synthesis of 5 3 104/ml CD40-activated sIgD1 B cultured 6 d in the absence or presence of 5 3 104/ml in vitro generated D-Lc with or
without IL-10 (200 ng/ml), TGF-b (0.3 ng/ml), or both. (D) For enumeration experiments, 5 3 104/ml sIgD1 B were cultured for 6 d in the presence
or absence of 5 3 104/ml D-Lc, with or without IL-10 (200 ng/ml) and increasing doses of TGF-b (0.1, 0.3, 1, and 3 ng/ml). Viable cells that were not
colored with Trypan blue dye were enumerated at day 6. One representative experiment is shown out of 4 in A and B, 6 in C, and 2 in D.1913 Fayette et al.
D-Lc provide an additional important sIgA inducing signal
that acts in concert with IL-10 and TGF-b to induce the
expression of surface IgA on almost half the naive B cells.
Dendritic Cells Skew Cytokine-dependent Ig Secretion towards
IgA. sIgD1 B cells triggered solely through their CD40
antigen did not secrete detectable Ig (17 and Fig. 5 A) and
Figure 3. D-Lc induce CD40-activated naive B cells to express sIgA. 5 3
104/ml sIgD1 B lymphocytes were cultured in a final volume of 1 ml in
the absence or presence of 5 3 104/ml D-Lc over 1.25 3 104/ml irradi-
ated CD40L-L cells without exogenous cytokine or with IL-10 (200 ng/
ml), TGF-b (0.3 ng/ml) or both (A), or with IL-10 and increasing doses
of TGF-b (B). B cells were harvested after 7 d of culture and stained with
rabbit polyclonal FITC-labeled anti-IgA or anti-IgG antibodies (A, B) or
FITC-labeled anti-IgA1 or -IgA2 mAbs (C) and analyzed by FACScanÒ.
Dead cells which incorporated propidium iodide were excluded. Histo-
grams are presented (A) or percentages of sIgG and sIgA positively stained
cells (B). One representative experiment out of six (A) and one out of
three (B) are shown.
Figure 4. Induction of sIgA by D-Lc is partially dependent on endoge-
nous TGF-b. 5 3 104/ml sIgD1 B lymphocytes were cultured in a final
volume of 1 ml in the absence or presence of 5 3 104/ml D-Lc over 1.25 3
104/ml irradiated CD40L-L cells without exogenous cytokine or with
IL-10 (200 ng/ml), TGF-b (0.3 ng/ml) or both. To neutralize IL-10 or
TGF-b, a rat monoclonal anti–IL-10 receptor antibody (mAb3F9) or a
rabbit polyclonal anti–TGF-b antibody (anti–TGF-b) were used at 10 or
50 mg/ml, respectively. B cells were harvested after 7 d of culture and
stained with rabbit polyclonal FITC-labeled anti-IgA and analyzed by
FACScanÒ. Dead cells that incorporated propidium iodide were ex-
cluded. One representative experiment out of six is shown.1914 Dendritic Cells Skew Isotype Switching Towards IgA1 and IgA2
further addition of D-Lc did not result in significant in-
creases of IgA, IgG, and IgM (Fig. 5 A). However, D-Lc
considerably enhanced (10–20-fold) the secretion of IgA
induced by IL-10 used alone or in combination with TGF-b
while the production of IgM and IgG were less signifi-
cantly affected (Fig. 5 A). In the absence of D-Lc, 0.3–3
ng/ml TGF-b enhanced the IL-10–induced IgA synthesis
of CD40-activated sIgD1 B cells, while inhibiting IL-10–
induced IgG and IgM synthesis (17 and Fig. 3 B). In the
presence of D-Lc, TGF-b increased IL-10–induced IgM
synthesis by twofold but retained its strong inhibitory effect
on the secretion of IgG (Fig. 5 B). D-Lc potentiated the se-
cretion by CD40-activated sIgD1 B cells of IgA1 and im-
portantly, induced the secretion of IgA2 in response to IL-10
Figure 5. D-Lc enhance cytokine-induced Ig secretion of CD40-activated naive B cells. 5 3 104/ml sIgD1 B lymphocytes were cultured for 14 d in a
final volume of 200 ml in the presence or absence of 5 3 104/ml D-Lc over 1.25 3 104/ml irradiated CD40L-L cells without exogenous cytokine or with
IL-10 (200 ng/ml), TGF-b (1 ng/ml), or both (A), or with IL-10 and increasing doses of TGF-b (B). IgA, IgG, or IgM levels in culture supernatants
were measured in specific ELISAs and results are expressed as mean 6 SD of triplicate cultures. One representative experiment out of eight (A) and three
(B), respectively, are shown.
Table 1. D-Lc Can Drive B Cells to Secrete Both IgA1 and IgA2 in Response to Cytokines
Experiment
IgA1 (ng/ml) IgA2 (ng/ml)
Without D-Lc With D-Lc Without D-Lc With D-Lc
1 IL-10 413 6 350 2456 6 1116 0 58 6 20
IL-10 1 TGFb 725 6 283 6051 6 812 5 6 2 180 6 69
2 IL-10 1125 6 117 6339 6 432 6 6 2 169 6 14
IL-10 1 TGFb 2091 6 215 8429 6 1113 12 6 4 307 6 41
3 IL-10 181 6 84 9492 6 966 0 583 6 174
IL-10 1 TGFb 507 6 344 15816 6 3844 0 806 6 287
5 3 104/ml slgD1 B lymphocytes were cultured for 14 d in a final volume of 200 ml in the presence or absence of 5 3 104/ml D-Lc over 1.25 3
104/ml irradiated CD40L-L cells with IL-10 (200 ng/ml) or with IL-10 1 TGFb (1 ng/ml). IgA1 and IgA2 levels in culture supernatants were mea-
sured in specific ELISAs as described in Materials and Methods. Results are expressed as mean 6 SD of triplicate cultures. 
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(Table 1). Addition of TGF-
 
b
 
 to cultures further enhanced
the secretion of both IgA subclasses.
Overall, D-Lc preferentially favored IgA synthesis in-
duced by IL-10 alone or in combination with TGF-
 
b
 
 at
the expense of IgG. This is illustrated in Fig. 6 which is a
compilation of the results of 23 experiments performed with
IL-10 and 8 experiments performed with IL-10 and TGF-
 
b
 
over a two-year period, using different batches of tonsillar
sIgD
 
1
 
 B cells and D-Lc CD34
 
1
 
-derived from distinct do-
nors.
 
Effects on B Cell Responses Are Strictly due to Dendritic
Cells.
 
Dendritic cells generated in vitro by culturing he-
matopoietic progenitors for 12 d in GM-CSF, TNF-
 
a
 
, and
SCF contain between 50–90% of CD1a
 
1
 
 cells. To exclude
the contribution of nondendritic cells, dendritic cells were
sorted on the basis of CD1a expression. As shown in Fig. 7 
 
A
 
,
purity of CD1a-sorted dendritic cells reached 95% (ranging
from 95 to 97%, 
 
n
 
 
 
5
 
 3). CD1a-sorted Dendritic cells were
capable to induce comparable levels of sIgA on CD40-acti-
vated sIgD
 
1
 
 B cells after 7 d of coculture in the presence of
IL-10 and TGF-
 
b
 
 than those obtained with unseparated
Figure 6. D-Lc favor IgA secretion to the expense of IgG. The effect
of D-Lc on the ratio of IgA versus IgG produced by CD40-activated na-
ive B cells cultured with IL-10 alone or in combination with TGF-b is
schematically represented. The figure represents the results of 23 experi-
ments for culture with IL-10 and 8 for IL-10 plus TGF-b with or with-
out D-Lc. These results are the compilation of different cultures per-
formed over a two-year period using different donors of sIgD1 B cells and
D-Lc.
 
D-Lc (30.1 versus 35.6%) (results obtained with CD1a-
sorted Dendritic cells: mean 29.2 
 
6
 
 0.8%, 
 
n
 
 
 
5
 
 3) (Fig. 7 
 
B
 
).
In addition, as observed with unseparated D-Lc, CD1a-
sorted Dendritic cells were able to potentiate IL-10-induced
IgA secretion by CD40-activated sIgD
 
1
 
 B cells (Fig. 7 
 
C
 
)
that was further increased in the presence of TGF-
 
b
 
.
To exclude a possible contribution to those effects of
contaminating T cells expanded by allogeneic D-Lc, the
presence of T cells was analyzed using the sensitive RT-
PCR for CD3 mRNA. As shown in Fig. 8, CD3 mRNA
could not be detected within (
 
a
 
) in vitro-generated D-Lc,
(
 
b
 
) MACS-purified sIgD
 
1
 
 B cells, (
 
c
 
) cocultures of D-Lc
and sIgD
 
1
 
 B cells even in the presence of IL-2. Likewise,
no CD3 mRNA could be detected in cocultures of D-Lc
Figure 7. Effects on B cell responses are strictly due to D-Lc. (A) Day
0, sorting of CD1a1 dendritic cells. (B) Day 7, induction of sIgA by
CD1a1-sorted dendritic cells. (C) Day 14, CD1a1-sorted dendritic cells
potentiate cytokine-induced IgA secretion. After 12 d maturation of
CD341 hematopoietic progenitors into dendritic cells, D-Lc were sorted
on the basis of CD1a expression (A). 5 3 104/ml sIgD1 B lymphocytes
were cultured in a final volume of 1 ml in the absence or presence of 5 3
104/ml unseparated or sorted CD1a1D-Lc over 1.25 3 104/ml irradiated
CD40L-L cells without exogenous cytokine or with IL-10 (200 ng/ml),
TGF-b (0.3 ng/ml) or both. Surface IgA on B cells was analyzed after 7 d
culture with IL-10 and TGF-b (B) and IgA secretion was measured at day
14 (C) as previously described.
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and sIgD1 B cells in the presence of IL-10 with or without
TGF-b (data not shown). Contaminating T cells could not
be detected under such culture conditions, thus demon-
strating that the results reported herein are only dependent
upon the interaction of Dendritic cells with CD40-acti-
vated sIgD1 B cells.
Discussion
The present study shows that DC skew humoral im-
mune response towards a mucosal type as demonstrated by
the induced switch and secretion of IgA1 and IgA2 by
CD40-activated naive B cells.
Our present observation significantly extends earlier stud-
ies performed with mouse and human B cells. As observed
with T cell–activated mouse B cells, DC can induce CD40
(T cell)-activated human B cells to switch towards IgA (32–
35). In this context, this present study brings about impor-
tant new information: (a) DC have a direct effect on B cells,
provided that B cells are activated through their CD40. (b)
in contrast to the unique IgA isotype in mice, humans bear
two IgA subclasses whose differential in vivo expression
suggests distinct regulation. Our data indicate an important
role for DC in allowing the production of IgA2, an isotype
that naive B cells cannot be induced to secrete in response
to cytokines (IL-10 and TGF-b) alone. (c) In vitro gener-
ated human DC share properties with DC isolated from
mouse secondary lymphoid organs such as spleen and Pey-
ers patches.
Although studies with human B cells indicated that both
IL-10 and TGF-b are involved in regulating the switch to-
wards IgA (17, 30), the IgA switch capacity of DC cannot
be solely ascribed to either or both of these cytokines. An-
tibodies neutralizing IL-10 did not affect DC-induced IgA
expression, while neutralizing anti–TGF-b only partially re-
duced the responses. Indeed, DC were reproducibly found
to induce the IgA switch more efficiently than the combi-
nation of TGF-b and IL-10. The unique nature of DC IgA
switching activity was also illustrated by the synergy ob-
served in sIgA induction when supplementing DC to the
combination of IL-10 and TGF-b. The DC molecule(s)
that induce(s) the IgA switch remain(s) to be determined
and preliminary experiments indicate that the effect cannot
be simply reproduced using cell-free supernatants from
D-Lc (activated or not), neither by separating physically D-Lc
from naive B cells.
Although DC are able to provide CD40-activated naive
B cells with the necessary signals to induce surface IgA ex-
pression, they are not able to directly induce naive B cells
to differentiate into IgA-secreting cells. However, when
IL-10 is added to provide the critical signal for this differ-
entiation to occur, then DC considerably enhance Ig secre-
tion. Interestingly, in the presence of IL-10 and TGF-b,
DC skewed Ig secretion towards IgA and importantly se-
cretion of both IgA1 and IgA2 subclasses is upregulated.
Our study analyses isotype switching to IgA1/IgA2 down
to the expression/secretion of the proteins, while earlier
studies on human B cells have essentially focused on the in-
duction of the germline and mature a1/a2 transcripts.
These molecular studies have provided some insights into
the complex regulation of IgA subclasses expression with
regard to cytokines/T cell signals. Naive B cells can be in-
duced to express: (a) germline a1 and a2 transcripts in re-
sponse to either TGF-b or CD40 triggering, (b) mature a1
transcripts in response to either a combination of TGF-b
and IL-10 or CD40 triggering, (c) mature a2 transcripts in
response to a combination of TGF-b, IL-10, and CD40
triggering (30, 36). Our results regarding the cell surface
expression and secretion of IgA1 and IgA2 proteins show
that (a) cell surface expression and secretion of IgA1 can be
induced in response to a combination of IL-10 and CD40
triggering (with or without exogenous TGF-b); and (b) cell
surface expression and secretion of IgA2 can be induced with
a combination of IL-10, dendritic cells and CD40 trigger-
Figure 8. T cells were never
detected whatever culture condi-
tions tested. Total RNA was ex-
tracted from 0.5–1 3 106 of each
cell type studied: JY (EBV cell
line), MT9 (T cell clone), unsep-
arated D-Lc, sIgD1 B cells alone
or cocultured 7 d at 5 3 104/ml
in a final volume of 2 ml in the
absence or presence of 5 3 104/
ml D-Lc over 1.25 3 104/ml ir-
radiated CD40L-L cells without
exogenous cytokine or with IL-2
(20 U/ml). Total RNA was
transcribed into cDNA and 35
cycles PCR were performed
with CD3 primer (lanes 2, 4, 6,
8, 10, 12, 14) or with b-actin
primer (lanes 1, 3, 5, 7, 9, 11,
13) as positive control. The size
of the PCR products are 567 bp
for CD3 and 661 bp for b-actin.1917 Fayette et al.
ing (with or without exogenous TGF-b). Thus DC pro-
vide a critical signal for the expression and the secretion of
IgA2 protein. However, the present data do not permit to
determine whether DC enhance an event that is otherwise
under the detection threshold or whether DC provide a
unique signal for expression/secretion of IgA2.
Our current demonstration of a direct functional effect
of DC on IgA switch of CD40-activated naive B cells fur-
ther extends our recent studies that showed that DC also
induce CD40-activated (a) memory B cells to secrete high
amounts of IgG and IgA and (b) naive B cells to produce
considerable levels of IgM in response to IL-2 (37). Taken
together, these effects may reflect physiological events
occurring in vivo. First, the interdigitating dendritic cells
within T cell–rich areas may be involved in the differentia-
tion of activated B cells into plasma blast cells that subse-
quently accumulate within medullary cords. Second, the
numerous DC found in the gut lining (38) may contribute
to the switching towards IgA1 and IgA2, which character-
izes mucosal responses. Importantly, the recent identifica-
tion of a new population of DC located within germinal
centers (39), a critical site for isotype switching (40), sug-
gests that some DC may directly be involved in the regula-
tion of isotype switching.
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